SCREENING TEST FOR CHLAMYDIA TRACHOMATIS IN WOMEN

女性沙眼衣原体筛查测试

• 批准号: 3489507
• 负责人: PAUL J LAWRENCE
• 金额: $ 5万
• 依托单位: LITMUS CONCEPTS, INC.
• 依托单位国家: 美国
• 财政年份: 1991
• 资助国家: 美国
• 起止时间: 1991-09-01 至 1992-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3489507
• 关键词: Chlamydia trachomatis; biomarker; chlamydial disease; clinical chemistry; colorimetry; communicable disease diagnosis; diagnosis design /evaluation; diagnostic tests; female; female reproductive system disorder diagnosis; genital secretion; human tissue; rapid diagnosis

DESCRIPTION: (Adapted from the applicants' abstract) Genital Chlamydia trachomatis infection is currently the most common Sexually Transmitted Disease in the United States. Although it is often relatively asymptomatic and causes serious sequelae, it is readily treatable. Therefore, it is an ideal target for widespread screening. However, current diagnostic methodologies are prohibitively expensive, time consuming and labor intensive. LCI proposes to demonstrate the basic technical feasibility of developing a calorimetric, presumptive screening test for genital Chlamydia infection in women which is suitable for on-site use by clinical personnel with different training and backgrounds. The LCI test will be rapid, simple, inexpensive, stable at room temperature, compact, and ideal for use in resource poor settings. In Phase II, the applicant organization will develop, optimize and format its screening test for Chlamydia. In Phase III, LCI will commercialize the finished product through a license arrangement with one of its corporate marketing partners.

描述：（改编自申请人摘要）生殖器衣原体 沙眼感染是目前最常见的性传播疾病 疾病在美国。 虽然它通常是相对无症状的 并有严重后遗症的话，是很容易治愈的。 因此，它是一个 是广泛筛查的理想目标。 目前诊断 这些方法昂贵、耗时、费力 密集。 LCI建议证明以下基本技术可行性： 开发一种生殖器衣原体的量热推定筛查试验 适用于临床人员现场使用 不同的训练和背景。 LCI测试会很快， 简单、廉价、室温下稳定、结构紧凑，是理想的使用方式 在资源贫乏的环境中。 在第二阶段，申请机构将 开发、优化和格式化衣原体筛查测试。 同相 LCI将通过许可证将成品商业化 与其企业营销合作伙伴之一达成协议。